EP3653213
Stilling á hematókrít með sprautuinndælingu á testósteróni með aðstoð nálar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.10.2014EP published:
21.2.2024EP application number:
19199484.7
EP translation filed:
29.4.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
6.10.2034Expiry date:
6.10.2026Next due date:
31.10.2026
Title in English:
HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONELanguage of the patent:
English
Timeline
Today
7.10.2014EP application
21.2.2024EP Publication
29.4.2024Translation submitted
15.6.2024Registration published
6.10.2026Expires
Owner
Name:
Antares Pharma, Inc.Address:
100 Princeton South Corporate Center Suite 300, Ewing, New Jersey 08628, US
Inventor
Name:
WOTTON, Paul K.Address:
Newton, PA Pennsylvania 18940, US
Name:
JAFFE, JonathanAddress:
Annandale, NJ New Jersey 08801, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361887643 PDate:
7.10.2013Country:
US
Classification
Categories:
A61K 31/56, A61P 15/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 22.10.2024
Expires: 6.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 22.10.2025
Expires: 6.10.2026
Payer: Árnason Faktor ehf.